European Society of Cardiology

The PARACHUTE-HF trial demonstrated that sacubitril/valsartan was superior to enalapril in treating heart failure caused by Chagas disease, with a 52% higher likelihood of better primary outcomes.

The DUAL-ACS trial found that 3 months of dual antiplatelet therapy (DAPT) showed signals for improved survival and lower bleeding risk compared to the standard 12-month duration in real-world heart attack patients.

Bempedoic acid has received a Class I, Level A recommendation in the 2025 ESC/EAS Guidelines for Management of Dyslipidaemias, marking the strongest endorsement for a non-statin therapy.

The DIGIT-HF trial demonstrated that digitoxin significantly reduced the composite risk of all-cause death or hospitalization for worsening heart failure by 18% compared to placebo in patients with heart failure with reduced ejection fraction.

ESC Congress 2025 will present over 40 pivotal cardiovascular studies in 10 Hot Line sessions from August 29 to September 1 in Madrid, focusing on global health priorities.

A novel machine learning model combining clinical, radiomic, and dosiomic parameters achieved 96% accuracy in predicting treatment-related cardiac events in breast cancer patients, significantly outperforming traditional clinical and dosimetric approaches (67% accuracy).

A pharmaceutically manufactured cannabidiol formulation demonstrated a favorable cardiac safety profile in patients with cardiovascular risk factors, according to research presented at Heart Failure 2025.

The GREG initiative, a five-year €26.2 million public-private partnership, has launched to advance Real-World Evidence practices for medicines and medical devices evaluation across Europe.

New research from Denmark shows antidepressant use is associated with an increased risk of sudden cardiac death, with risk rising based on duration of exposure.

New research from the University of Trieste shows prompt CPR initiation significantly improves cardiac arrest survival rates, regardless of whether performed by bystanders or medical professionals.